Exercise is a cornerstone of type 2 diabetes care, yet clinicians often struggle with translating broad guidelines into practical, individualized “exercise prescriptions.” The focus keyword in this article, exercise prescription for type 2 diabetes, reflects a high‑intent search term that clinicians, diabetes educators, and patients frequently use when seeking actionable …
Read More »The Expanding Landscape of Diabetes Complications: Liver Disease, Cancer, and Frailty
Early in training, many clinicians learn the classic “eye–kidney–foot” framework for recognizing and managing complications of diabetes. However, as science advances, the range of recognized consequences of diabetes—and opportunities for earlier intervention—continues to broaden. Today, the concept of diabetes complications screening must evolve to include conditions such as metabolic dysfunction–associated …
Read More »Beyond GLP‑1s: Are We Overlooking the Role of SGLT2 Inhibitors and Metformin?
Clinicians and care teams are increasingly focused on GLP‑1 receptor agonists, but SGLT2 inhibitors and metformin in diabetes management remain foundational in achieving comprehensive, evidence‑based outcomes. While GLP‑1 therapies generate headlines for weight loss and glucose control, 2025 guidelines still strongly emphasize the cardioprotective and renoprotective benefits of SGLT2 inhibitors …
Read More »When Diabetes Isn’t the Main Problem: Managing Comorbidities Without Losing Focus
Living with type 2 diabetes often means managing more than just blood glucose. For many patients, conditions like cardiovascular disease, chronic kidney disease, or depression take center stage in their care plan. When diabetes isn’t the main problem, how do you keep glucose control on track without compromising treatment for …
Read More »From A1C to TIR – Rethinking Glycemic Targets for Better Long‑Term Outcomes
For decades, clinicians have relied on A1C as the primary benchmark for diabetes control. Yet many patients and providers now wonder: does a single quarterly number truly reflect daily glucose fluctuations and risks? As continuous glucose monitoring (CGM) becomes more accessible, the metric known as Time in Range (TIR) has …
Read More »Should We Be Prescribing Exercise as a Formal Diabetes Intervention?
When treating patients with diabetes, lifestyle advice such as “eat healthy” and “stay active” is often routine. But what if we took that a step further and issued a formal exercise prescription — in other words, ordering physical activity like we would a drug? Recent research suggests that a structured …
Read More »The Case for Early Insulin: Rethinking Delayed Initiation in Type 2 Diabetes
Starting insulin early in the course of type 2 diabetes may seem counter‑intuitive. After all, many patients and clinicians treat insulin as a “last resort.” Yet what if early insulin initiation could actually change the trajectory of the disease — preserving pancreatic function, improving long‑term control, and reducing complications? In …
Read More »Effective Type 2 Diabetes Management Strategies for Clinicians
Explore effective type 2 diabetes management strategies for clinicians, focusing on lifestyle, medication, and monitoring for optimal patient care.
Read More »Symptoms of Type 2 Diabetes: What Healthcare Professionals Should Know
Discover key symptoms of Type 2 Diabetes for early detection and effective management, crucial for healthcare professionals.
Read More »Case of Medication-Induced Weight Gain and Diabetes
Ginna S. Eynon, PharmD Candidate 2026 Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Department of Pharmacotherapy College of Pharmacy and Pharmaceutical Sciences Washington State University A 29-year-old female with a history of schizophrenia and depression was referred for a pharmacotherapy evaluation by her social work case manager. During a recent …
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.